Functional Characterization Experiment summary for ENCSR689KVW

doi:10.17989/ENCSR689KVW

Summary

Status
released
Assay
proliferation CRISPR screen
Biosample summary
Homo sapiens OCI-AML2 genetically modified (insertion) using transduction, using CRISPRi (sgRNA)
Biosample Type
cell line
Perturbation type
CRISPRi
Tiling modality
sparse peak
Replication type
isogenic
Description
CRISPR-dCas9-based epigenomic regulatory element screening (CERES) technology to screen a subset of putative non-coding regulatory elements identified in human K562 leukemia cells from whole genome discovery screen (validation). This validation screen was performed in OCI-AML2 acute myeloid leukemia cells
Nucleic acid type
DNA
Controls
Elements references

Attribution

ENCODE4 project
Lab
Tim Reddy, Duke
Award
UM1HG009428 (Tim Reddy, Duke)
Project
ENCODE
Aliases
charles-gersbach:encode4-ceres-dcas9-krab-validation-screen-ociaml2
Date submitted
August 31, 2021
Date released
October 20, 2022
Functional Characterization Series
ENCSR179FSH 
Submitter comment
dCas9-KRAB

Isogenic replicates

Isogenic replicate
Technical replicate
Summary
Biosample
Modifications
Library
11Homo sapiens OCI-AML2 cell line genetically modified (insertion) using transduction, genetically modified using CRISPRi (sgRNA)ENCBS091HPBENCGM710IEC, ENCGM809XEKENCLB639QZP
31Homo sapiens OCI-AML2 cell line genetically modified (insertion) using transduction, genetically modified using CRISPRi (sgRNA)ENCBS720FRSENCGM710IEC, ENCGM809XEKENCLB517IHN
21Homo sapiens OCI-AML2 cell line genetically modified (insertion) using transduction, genetically modified using CRISPRi (sgRNA)ENCBS530LLDENCGM710IEC, ENCGM809XEKENCLB190BOQ
41Homo sapiens OCI-AML2 cell line genetically modified (insertion) using transduction, genetically modified using CRISPRi (sgRNA)ENCBS554DTMENCGM710IEC, ENCGM809XEKENCLB581WFS